Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
IGM Biosciences Inc (IGM Biosciences) is a biotechnology company that provides antibody medicines for the treatment of autoimmune and inflammatory diseases. It carries out the development and engineering of therapeutic IgM antibodies, leveraging their greater binding power compared to traditional IgG antibodies. IGM Biosciences' products include these engineered IgM antibodies, which are designed to offer novel therapeutic options. The company primarily serves patients with autoimmune and inflammatory diseases, exploring new approaches to treatment through its innovative antibody platform. IGM Biosciences is headquartered in Mountain View, California, the US.
Headquarters
United States of America
Address
325 E Middlefield Rd, Mountain View, California, 94043-4003
Website
igmbio.com
Telephone
1 650 9657873
No of Employees
16
Industry
Pharmaceuticals and Healthcare
Revenue (2024)
$2.7M
IGM Biosciences Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Engineered IgM Antibodies |
| Therapeutic IgM Antibodies |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Ownership Changes | In August, the company was acquired by Concentra Biosciences, LLC, a biosciences company. |
| 2024 | Contracts/Agreements | In April, the company partnered with Sanofi to create and develop IgM agonist antibodies to focus on immunology/inflammation targets. |
| 2023 | Plans/Strategy | In November, the company announced its plans to raise up to US$400 million in public offering of securities. |
Competitor Comparison
| Key Parameters | IGM Biosciences Inc | Que Oncology Inc | SELLAS Life Sciences Group Inc | Benecyte Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | Mountain View | Atlanta | New York City | Durham |
| State/Province | California | Georgia | New York | North Carolina |
| No. of Employees | 16 | - | 15 | 49 |
| Entity Type | Private | Private | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mary Beth Harler, M.D. | Director; Chief Executive Officer | Executive Board | 2024 | 60 |
| Misbah Tahir | Chief Financial Officer | Senior Management | 2019 | 50 |
| Steven Weber | Controller - Corporate; Senior Vice President | Senior Management | 2022 | - |
| Lisa L. Decker, Ph.D. | Chief Business Officer | Senior Management | 2021 | 56 |
| TS Harigopal | Senior Vice President - Group Operations | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer